Health
Oxford vaccine stimulates broad antibody and T cell functions – Medical Xpress
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing…
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
These findings are reported in two papers, both released in the peer-reviewed journal Nature Medicine.
Previous studies have shown that in order to develop any vaccine against SARS-CoV-2 coronavirus,…
-
Noosa News22 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News24 hours agoFuel tanker racing to unload in Darwin ahead of Tropical Cyclone Fina
-
Noosa News20 hours agoSeven key takeaways from the Queensland probe’s first week
-
General22 hours agoWaste from Perth set to be trucked out to York after WA minister approves landfill site